Yahoo
Advertisement
Advertisement
Deadline

The Who’s Veteran Frontman Roger Daltrey Shares Health Condition Live Onstage

Caroline Frost
2 min read
  • Roger Daltrey, lead singer of The Who, revealed at a concert that he is experiencing hearing and vision problems due to aging.

The Who's longtime frontman Roger Daltrey has shared details of his health battles with a live audience at London's Royal Albert Hall.

The Sun newspaper reports that the veteran rocker spoke to fans from the stage and told them: "The joys of getting old mean you go deaf, I also now have got the joy of going blind. Fortunately I still have my voice, because then I'll have a full Tommy." 

More from Deadline

Advertisement
Advertisement

He was referring to Tommy , the title of the band's 1969 rock opera album, which follows the story of Tommy Walker, who retreats into a catatonic state after witnessing a traumatic family event, becoming "becomes deaf, dumb and blind." 

Daltrey previously announced onstage in 2018 that he had suffered hearing loss as a result of exposure to loud noise levels during music performances and was now "very, very deaf." He urged audience members to use earplugs.

Daltrey formed The Who in 1964 with songwriter Pete Townshend, who still performs alongside him. At the same concert, Townshend joked about his knee replacement, saying: "Maybe I should auction off the old one. Elton John had one done, and he wears his as a bracelet. Unfortunately, mine's in three bits." 

The Who were inducted into the Rock and Roll Hall of Fame in 1990. Former band members include the late bassist John Entwistle and drummer Keith Moon. They are cited as a formative influence on many rock bands of the 20th century, with their innovative use of the Marshall stack system and incorporating synthesizers into their production. Their work includes such classic songs as "Baba O'Riley," "Won't Get Fooled Again," "My Generation," "Pinball Wizard" and "Who Are You" and essential albums Who's Next, Quadrophenia, Who Are You and The Who by Numbers .

Best of Deadline

Sign up for Deadline's Newsletter . For the latest news, follow us on Facebook , Twitter , and Instagram .

Advertisement
Advertisement
Advertisement
Mobilize your Website
View Site in Mobile | Classic
Share by: